Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
34 /100
MEDIUM RISK
Score updated Aug 28, 2026

NPCE — NeuroPace, Inc. Dilution Risk Tracker

Track NPCE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NPCE — Get alerts when the score changes →

As of August 28, 2026, NeuroPace, Inc. (NPCE) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. NeuroPace, Inc. has a market capitalization of $563.91M, 34.32M shares outstanding, 112 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
25
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NPCE.
🔔 Track NPCE — Get forecast alerts →

Market Data

Market Cap$563.91M
Shares Outstanding34.32M
Float23.31M
Cash$51.70M
Debt$59.01M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 24.8% shares (2026Q1 vs prior)
112 institutional holders · 33.14M shares
#1 MORGAN STANLEY 7.66M shares
#2 Polar Capital Holdings Plc 3.30M shares
#3 Soleus Capital Management, L.P. 2.93M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest822.1K
Days to Cover3.9
% of Float3.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual NPCE Dilution Snapshot

NeuroPace, Inc. (NPCE) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track NPCE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NPCE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations